Americans For Safe Access - Honolulu, Hawaii  

Honolulu ASA HomePress ReleasesContact Honolulu ASA




About Us

F.A.Q. Service
Newsflash
Myths vs. Facts
History of Medical Cannabis
Cannabis Strains

Therapeutic Uses of Cannabis
Clinical Studies & Reports
Run From The Cure

Madrid Study
Cannabis for Migraine Treatment
Medical Cannabis States
Cannabis and Religion
The Cannabis Conspiracy
Cannabis Cookbook
Legal Information

Becoming a Medical Marijuana Patient in Hawaii
Hawaii Revised Statutes §329 Part IX
Tenth Amendment
DEA Raid Videos
Testimonial Videos
Tutorial Video Library
Video Screenings
Hawai Medical Marijuana News Headlines
Sign our Guestbook
Visit the Honolulu ASA Store
Join Honolulu ASA
Chapter Meetings
Participating Physicians
Resources & Links

 

Chapter Websites
Big Island ASA Chapter
San Diego ASA Chapter
Orange County ASA Chapter
Eastern Shore ASA Chapter
Western North Carolina ASA Chapter


National Website
ASA Headquarters
About the ASA
What We Do
ASA Press Room
Email Alerts
Take Action
Patients Unions
ASA Community Forums

 

 

 

US ZIP Codes

 

 

 

 

 

Clinical Studies and Case Reports

 

TitleTHC improves appetite and reverses weight loss in AIDS patients
Author(s)Dejesus E, Rodwick BM, Bowers D, Cohen CJ, Pearce D
Journal, Volume, IssueJ Int Assoc Physicians AIDS Care 2007;6(2):95-100.
Major outcome(s)THC improved appetite and weight and reduced nausea
 
IndicationNausea/vomiting;Appetite loss/weight loss;HIV/AIDSAbstract
MedicationDelta-9-THC

Objective: To determine whether dronabinol affects appetite and weight status in patients living with HIV/AIDS. METHODS: A retrospective chart review was conducted to analyze weight and appetite changes and nausea status in patients with HIV/AIDS who received dronabinol for 3 to 12 months from January 11, 1993, to March 17, 2003. RESULTS: Of the 117 patients who lost weight before baseline, 63% maintained or gained weight. In patients receiving dronabinol for 1 year, the mean weight gain (+/- SD) was 3.7 +/- 10.6 lb. The percentage of patients experiencing loss of appetite decreased significantly from 71% at baseline to 26% at 1 month (P < .001) and continued to decline throughout the trial. The percentage of patients experiencing nausea at baseline (38%) decreased consistently from week 2 on; this change from baseline was significant at month 6 (P = .031). CONCLUSION: When taken for 3 months to 1 year, dronabinol significantly improves appetite and reverses weight loss in patients living with HIV/AIDS.

Route(s)Oral
Dose(s) 
Duration (days)90-365
Participants117 patients with HIV/AIDS
DesignOpen study
Type of publicationMedical journal
Address of author(s)Orlando Immunology Center, Orlando, Florida, edejesus@oicorlando.com.
Full text
 

 

Report Hawaii Medical Marijuana Arrests to 808-233-9803

 

 

 




© Copyright 2009 Honolulu ASA. Honolulu ASA is the Honolulu, Hawaii chapter of Americans for Safe Access. We are required by federal law to tell you that any donations you make to Honolulu ASA may be used for political purposes, such as supporting or opposing candidates for federal office. Website designed and hosted by FRWebservices. For problems or questions regarding this Web site contact our Webmaster
Last updated: 11/26/09.